Literature DB >> 26398069

Deception by Research Participants.

David B Resnik1, David J McCann.   

Abstract

Study participants who fabricate, falsify, or fail to disclose important information can undermine the integrity of clinical trials, with negative consequences for both future patients and the participants themselves. What can investigators do to address the problem?

Entities:  

Mesh：

Year:  2015        PMID： 26398069     DOI： 10.1056/NEJMp1506985

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

Review 2.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

3.  When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation.

Authors:  Stacy A Kahn; David T Rubin
Journal:  Am J Gastroenterol       Date:  2016-05-10       Impact factor: 10.864

Review 4.  Detecting Deception in Our Research Participants: Are Your Participants Who You Think They Are?

Authors:  Mary E McCaul; Gary S Wand
Journal:  Alcohol Clin Exp Res       Date:  2017-12-29       Impact factor: 3.455

5.  Safety, Science, or Both? Deceptive Healthy Volunteers: Psychiatric Conditions Uncovered by Objective Methods of Screening.

Authors:  Adriana Pavletic; Maryland Pao
Journal:  Psychosomatics       Date:  2017-05-09       Impact factor: 2.386

6.  False-positive HIV diagnoses: lessons from Ugandan and Russian research cohorts.

Authors:  Sharon M Coleman; Natalia Gnatienko; Christine A Lloyd-Travaglini; Michael R Winter; Carly Bridden; Elena Blokhina; Dmitry Lioznov; Julian Adong; Jeffrey H Samet; Teri Liegler; Judith A Hahn
Journal:  HIV Clin Trials       Date:  2018-01-31

7.  To report or not to report: Exploring healthy volunteers' rationales for disclosing adverse events in Phase I drug trials.

Authors:  Lisa McManus; Jill A Fisher
Journal:  AJOB Empir Bioeth       Date:  2018 Apr-Jun

8.  Commentary on Zvonareva et al.: Exploring the many meanings of "professional" in research participation.

Authors:  Jill A Fisher
Journal:  Clin Trials       Date:  2019-10-05       Impact factor: 2.486

Review 9.  A Critical Review of Alcohol Administration Guidelines in Laboratory Medication Screening Research: Is It Time to Include Treatment Seekers?

Authors:  Walter Roberts; Terril L Verplaetse; Vijay A Ramchandani; Sherry A McKee
Journal:  Alcohol Clin Exp Res       Date:  2020-12-20       Impact factor: 3.928

10.  Are Payments to Human Research Subjects Ethically Suspect?

Authors:  David B Resnik
Journal:  J Clin Res Best Pract       Date:  2019-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.